Recombinant Antibodies to the Ebola Virus Glycoprotein

Currently, there are no approved therapies for targeted prevention and treatment of Ebola hemorrhagic fever. In the present work, we describe the development of a eukaryotic expression system for the production of three full-length chimeric antibodies (IgG1-kappa isotypes) GPE118, GPE325, and GPE534...

Descripción completa

Detalles Bibliográficos
Autores principales: Panina, A. A., Dementieva, I. G., Aliev, T. K., Toporova, V. A., Balabashin, D. S., Bokov, M. N., Pozdnyakova, L. P., Shchemchukova, O. B., Dolgikh, D. A., Sveshnikov, P. G., Kirpichnikov, M. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: A.I. Gordeyev 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762832/
https://www.ncbi.nlm.nih.gov/pubmed/29340221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762832/
https://www.ncbi.nlm.nih.gov/pubmed/29340221

Ejemplares similares